Management of hemophilia in developing countries

Indian Journal of Pediatrics

Volumn 68, Issue 2, 2001, Pages 151-157

  Kashyap, Rajesh ^a   Choudhry, V P ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Hemophilia; Management; Moleculer diagnosis

Indexed keywords

AMINOCAPROIC ACID; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING FACTOR 9 COMPLEX; BLOOD CLOTTING FACTOR 9 CONCENTRATE; DESMOPRESSIN ACETATE; FIBRIN GLUE; HEMOSTATIC AGENT; PROFILNIRE; RECOMBINANT BLOOD CLOTTING FACTOR 8; RECOMBINANT BLOOD CLOTTING FACTOR 9; TRANEXAMIC ACID;

BLOOD CLOTTING FACTOR DEFICIENCY; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CONFERENCE PAPER; DEVELOPING COUNTRY; DRUG SAFETY; EMERGENCY TREATMENT; HEMARTHROSIS; HEMOPHILIA A; HEMOPHILIA B; HUMAN; INDIA; VIRUS INFECTION;

EID: 0035087126     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02722035     Document Type: Conference Paper

References (21)

1. Srivastava A, Chuansumrit A, Chandy M, Duraiswam G,Karagus C. Management of hemophilia in the developing countries. Hemophilia 1998; 4 : 474-480.
2. Choudhry VP, Kashyap R, Saxena R. Management of hemophilia in developing countries: An Indian experience: Hemophilia 1996; 2 : 141-144.
3. Chandy M. Management of hemophilia in developing countries with available resources. Hemophilia 1995 : 1 (suppl 1) : 44-48.
4. Hoyer LW, Hemophilia A. N Engl J Med 1994; 330 : 38-47.
5. Buttler DB, Levine PH. Clinical manifestation and therapy in inherited coagulation factor deficiencies, Sazman EW. In Colman RW, Hirsh J, Marder JW, eds. Hemostasis and thrombosis: Basic Principles and Practice, 3rd edn. Philadelphia, J.B. Lippincott, 1994; 169-183.
6. Kashyap R, Choudhry VP. Hemophilia. Indian Pediatr 2000; 37 : 45-53.
7. Martinowitz U, Schulman S, Gitel S, Horozowski H, Hein M and Varon S. Adjusted dose continuous infusion of factor VIII in patients with hemophilia A. Br J Hematol 1992; 82 : 729-734.
8. DiMichele DM, Lasak ME, Miller CH. In vitro factor VIII recovery during the delivery of ultrapure factor VIII concentrate by continuous infusion. Am J Hematol 1996; 51 : 99-103.
9. Hathway WE, Christine MJ, Clarke SL and Hasiba U. Comparsion of continuous and intermittent factor VIII concentrate in hemophilia A. Am J Hematol 1984; 17 : 85-88.
10. Hermens WTH. Dose calculation of human factor VIII and factor IX concentrates for infusion therapy. In Brinkhouse KM, Hemker HC, eds. Handbook of Hemophilia, Part II. New York. American Elsevier Publishing, 1975; 569-589.
11. Lusher JM. Thrombogenocity associated with factor IX complex concentrates. Semin Hemat 1991; 28 : 3-5.
12. Fletcher ML, Trowell JM, Craske J Pavierk, Pizza CR. Non A, Non B hepatitis after transfusion of factor VIII in unfrequently treated hemophilics. Clin Res, edn. Br Med J 1983; 287 : 1754-1757.
13. Roberts HR. The treatment of hemophilia. Past tregedy and future promise. N Engl J Med 1989; 321 : 1188-1189.
14. Mannuci PM. Modern treatment of hemophilia from the shadow towards the light. Thromb Hemostat 1993; 70 : 17-23.
15. Leathagen S, Harris AS, Sjorin E and Nilsson IM. Intranasal and intravenous administration of deismopression effects on F VIII, WF, phamacokinetics and reproducibility. Thromb Hemostat 1987; 58 : 1033-1036.
16. Aledort LM. Some aspect in the management of hemophilia. Thromb Hemostat 1995; 75 : 440-443.
17. Martinowitz U, schulman S, Horoszwski J, Heim M. Role of fibrin sealants in surgical procedures in patients with hemostatic disorders. Clin Orthop 1996; 328 : 67-75.
18. Battistellar LR. Rehabilitation in haemophilia options in developing world. Hemophilia 1998; 4 : 486-490.
19. Arnold WD, Hilgartner MW. Hemophilic arthropathy. current concept of pathogenesis and management. J Bone Joint Surg Am 1997; 59A : 287-305.
20. Klein KS, Al and CM, Kin KM, Eisile J, Saidi P. Long term follow up arthroscopic synovectomy for chronic hemophilic synovitis. Arthroscopy 1987; 3 : 231-236.
21. Caviglia H, Galatro G, Duhalcle C and Perez-Bianco R. Hemophilic synovitis: is rifampicin an alternative? Hemophilia 1998; 4 : 514-517.